HealthQuill Astra Zeneca Plc.
AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without the disease progressing or getting worse, according to the Anglo-Swedish company.
Drugs Medical Pharma

AstraZeneca’s test drug for breast cancer fails to prolong life

HQ Team September 13, 2026: AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without.

Read More
AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live longer, company data from an end-stage study reveals.
Drugs Health Pharma

AstraZeneca’s therapy for a type of lung cancer helps patients live longer 

HQ Team July 21, 2025: AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live.

Read More
Anglo-Swedish AstraZeneca Plc., and Japan’s Daiichi Sankyo’s therapy to treat a certain form of breast cancer has been approved by the US drug regulator in the adult population. 
Drugs Health Pharma

AstraZeneca-Daiichi’s breast cancer drug gets broader US nod

Anglo-Swedish AstraZeneca Plc., and Japan’s Daiichi Sankyo’s therapy to treat a certain form of breast cancer has been approved by the US drug.

Read More